* Made in Europe New treatment options increase Aurora’s commitment to patients in United kingdom
Berlin – Aurora Hempthe world’s leading manufacturer of medical cannabis, has launched three new cannabis extracts for patients in United kingdom. Available from May, produced in the Aurora Nordic in Odense, Denmark, the extracts have a particularly rich terpene profile. Terpenes with cannabis are an important contributor to the therapeutic effect of cannabis.
At Aurora Nordic, a new extraction process has been developed to ensure the terpene profile of their products remains at a consistently high level. The extraction process is based on identical types of flowers and results in reliable concentrations of active ingredients and consistent terpene profiles, ensuring treatment safety and tolerability. New Aurora extracts will expand the range of possible treatment options for patients in United kingdom.
I entered Aurora United kingdom The medical cannabis market in 2019, just a few months after legalization. Although thousands of patients benefit from medical cannabis today, widespread access is still elusive and many obstacles remain.
“We continue to strive to provide access to all patients prescribed medical cannabis and advocate for reimbursement and affordability through NHS financing. We are committed to helping improve access to medical education for healthcare professionals and are excited to share our knowledge and experience in the field of medical cannabis.” Trisha CassidyGeneral Director, Aurora UK & Ireland. “The efficacy and tolerability of medical cannabis has already been demonstrated in numerous clinical studies and in more than 20,000 . data United kingdom Patients will become available once first patients register for medical cannabis in Europe has been completed. The United kingdom The market is still young and a lot of work needs to be done to dismantle the obstacles that still prevent patients from receiving the treatment they need. Aurora is committed to these patients and will continue her dedicated work in United kingdom. ”
Aurora, a passionate advocate for patient access to medicinal cannabis and market leader in premium dried flowers for United kingdom And Europeproduces the majority of its medical cannabis products for the European market at a state-of-the-art manufacturing facility in Aurora Nordic in Odense, Denmark. Aurora adheres to the strictest regulations for European Union-GMP (Good Manufacturing Practice) and its topical advantage is appreciated for providing a safe supply to patients in United kingdom.
About Aurora EuropeAurora Europe, headquartered in Berlin Germanyis a subsidiary of Aurora Cannabis Inc., a leading global cannabis company serving both the medical and consumer markets and dedicated to helping people improve their lives. Aurora Europe Provides high quality medical cannabis products to patients around the world Europe. Aurora is one of the largest authorized importers and distributors of medical cannabis in EU & The United kingdom With a production and distribution facility in Denmark With a maximum annual production of 10 tons. . Aurora’s Inner Network European Union GMP facilities provide high quality, high quality medical cannabis to patients all over the world. For more information, please visit www.auroramedine.com or follow us at www.linkedin.com/company/aurora-europe.
Distributed through https://pressat.co.uk/